Feedback / Questions
cysteamine-pantetheine disulfide (TTI-0102) - Thiogenesis Therap
https://www.theglobeandmail.com/investing/markets/stocks/TTI-X/pressreleases/33044957/thiogenesis-receives-confirmatory-guidance-on-impd-for-pediatric-mash-phase-2a-clinical-trial-in-europe-and-core-patent-granted-in-eu/
Jun 25, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next